BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to MHCC97-H cell line is 45
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MSI2 | 18585 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | Western Blotting and IF staining followed by SFA | NA | 0.52 | 0.0011 | 31888685 |
| BMI1 | 1066 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.1135 | 32229502 |
| BMI1 | 1066 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | Western Blotting followed by SFA and CFA | NA | 0.48 | 0.1135 | 30908631 |
| NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.5461 | 32229502 |
| NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | Western Blotting and SFA | NA | 0.48 | 0.5461 | 31888685 |
| NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | Western Blotting followed by SFA and CFA | NA | 0.48 | 0.5461 | 30908631 |
| NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | CFA followed by SFA and qRT-PCR | NA | 0.48 | 0.5461 | 27783993 |
| NANOG | 20857 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.5461 | 25676692 |
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 32229502 |
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | Western Blotting and SFA | NA | 0.48 | 0.6448 | 31888685 |
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | Western Blotting followed by SFA and CFA | NA | 0.48 | 0.6448 | 30908631 |
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | CFA followed by SFA and qRT-PCR | NA | 0.48 | 0.6448 | 27783993 |
| POU5F1 | 9221 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.6448 | 25676692 |
| SOX2 | 11195 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.5695 | 32229502 |
| SOX2 | 11195 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | Western Blotting and SFA | NA | 0.48 | 0.5695 | 31888685 |
| SOX2 | 11195 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | Western Blotting followed by SFA and CFA | NA | 0.48 | 0.5695 | 30908631 |
| SOX2 | 11195 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | CFA followed by SFA and qRT-PCR | NA | 0.48 | 0.5695 | 27783993 |
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0371 | 32229502 |
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | Western Blotting followed by SFA and CFA | NA | 0.48 | 0.0371 | 30908631 |
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | CFA followed by SFA and qRT-PCR | NA | 0.48 | 0.0371 | 27783993 |
| THY1 | 11801 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.0371 | 25676692 |
| CD44 | 1681 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | Western Blotting followed by SFA and CFA | NA | 0.28 | 1 | 30908631 |
| CD44 | 1681 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | FACs followed by SFA | NA | 0.28 | 1 | 31888685 |
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | Western Blotting followed by SFA and CFA | NA | 0.28 | 0.211 | 30908631 |
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | CFA followed by SFA and qRT-PCR | NA | 0.28 | 0.211 | 27783993 |
| EPCAM | 11529 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.211 | 25676692 |
| HIF1A | 4910 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | Western Blotting followed by SFA and CFA | NA | 0.28 | 0.0106 | 30908631 |
| NOTCH1 | 7881 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | Western Blotting followed by SFA and CFA | NA | 0.28 | 0.0477 | 30908631 |
| CD24 | 1645 | HTM/LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.456 | 25676692 |
| DHCR7 | 2860 | HTM/LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0064 | 25676692 |
| FASN | 3594 | HTM/LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0074 | 25676692 |
| HMGCS1 | 5007 | HTM/LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0074 | 25676692 |
| IGFBP3 | 5472 | HTM/LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0095 | 25676692 |
| MIR100 | 31487 | HTM/LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0032 | 25676692 |
| MIR1269A | 35337 | HTM/LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 25676692 |
| MIR1269B | 41787 | HTM/LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 25676692 |
| MIR15B | 31544 | HTM/LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0085 | 25676692 |
| MIR210 | 31587 | HTM/LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0064 | 25676692 |
| MIR215 | 31592 | HTM/LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0021 | 25676692 |
| MIR22 | 31599 | HTM/LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0021 | 25676692 |
| MVD | 7529 | HTM/LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0042 | 25676692 |
| NDGG1 | NA | HTM/LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0011 | 25676692 |
| ODC1 | 8109 | HTM/LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by Transcriptomics and qRT-PCR | Up | 0.24 | 0.0021 | 25676692 |
| TGFB1 | 11766 | HTM/LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | SFA followed by Transcriptomics and qRT-PCR | NA | 0.24 | 0.0138 | 25676692 |
| PROM1 | 9454 | LTM | Hepatic Cancer | Carcinoma | MHCC97-H | NA | CFA followed by SFA and qRT-PCR | NA | 0.2 | 0.7582 | 27783993 |